OmniAb, Inc. (OABI)
NASDAQ
Closed
Oct 9, 2026
Day's Range
4.5952 wk Range
1.30Overview - OABI - OmniAb, Inc.
Key Statistics
Valuation
Enterprise Value
663.33M
P/E (Trailing)
-8.38
P/E (Forward)
-16.37
PEG Ratio
0.12
Price / Sales (TTM)
18.10
Price / Book
2.67
EV / EBITDA
-30.71
Profitability
Gross Margin
95.45%
Profit Margin
-115.11%
Operating Margin
-49.47%
Return on Assets
-8.34%
Return on Equity
-16.95%
Ownership
Shares Outstanding
145.39M
Float
118.24M
Short % of Shares Outstanding
6.19%
Held by Insiders
15.28%
Held by Institutions
52.79%
Price stats
Beta
1.37
50-Day Avg
4.13
200-Day Avg
2.48
Analyst Consensus
7 analysts
Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - OABI - OmniAb, Inc.
Peers - OABI - OmniAb, Inc.
Peer Comparison
Compared with companies in Biotechnology listed on NASDAQ.
- OABINASDAQOmniAb, Inc.696.42MMarket Cap+66.18%52-week change-8.39P/E (Trailing)-115.11%Profit Margin
- ARGXNASDAQArgenx SE54.66BMarket Cap+4.54%52-week change30.26P/E (Trailing)31.73%Profit Margin
- ALNYNASDAQAlnylam Pharmaceuticals, Inc.29.97BMarket Cap-110.32%52-week change37.78P/E (Trailing)16.12%Profit Margin
- BNTXNASDAQBioNTech SE American Depositary Share22.13BMarket Cap-20.35%52-week change160.80P/E (Trailing)-63.63%Profit Margin
- ASNDNASDAQAscendis Pharma A/S16.01BMarket Cap+16.49%52-week change18.23P/E (Trailing)70.84%Profit Margin
- BBIONASDAQBridgeBio Pharma Inc.12.97BMarket Cap+15.27%52-week change-17.56P/E (Trailing)-97.02%Profit Margin
- BMRNNASDAQBioMarin Pharmaceutical Inc.10.58BMarket Cap+1.57%52-week change147.76P/E (Trailing)2.14%Profit Margin
Profile Summary - OABI - OmniAb, Inc.
About
OmniAb, Inc. is a biotechnology company that licenses discovery research technology to pharmaceutical and biotech companies and academic institutions. OmniAb’s platform is designed to support the discovery of next-generation therapeutics by creating and screening diverse antibody repertoires, helping partners identify…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
